Markets

Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that management will participate in a fireside chat at the Jefferies Global…

SOFR Academy, Inc., a leading financial engineering firm, today announced the appointment of R. Martin “Marty” Chávez as Senior Advisor. Widely regarded as one of the most influential figures at…

All amounts are in U.S. Dollars unless otherwise indicated: THIRD QUARTER 2025 HIGHLIGHTS Average production for the third quarter of 2025 was 4,254 BOEPD, an increase of 40% from the…

Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company developing first-in-class therapies targeting claudin-1 for a range of fibrosis and oncology indications, today announced the appointment of Bryan Yoon as General Counsel…

With These New Product and Partnership Innovations, Samsara Reinforces its Leadership in Connected Operations Technology Across Europe

Strategic collaboration delivers advanced fraud detection and authentication for UK contact centres

Global survey of C-suite supply chain decision-makers highlights a shift towards autonomous intelligent supply chains. This new and fully data driven model is based on AI, regionalization, and circularity in…

Helping consumers pay down credit cards, auto loans, overdrafts, and other high-interest debt with a lower-cost loan

Exstent, a UK-based medical device company, developing personalised external aortic support to preserve the native aorta, today announced the appointment of Matt Thompson as Chief Executive Officer to lead its…

Venture Global’s third long-term contract with a Japanese company 6.75 MTPA of long-term contracts signed by Venture Global to date in 2025